Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
for Ventricular Arrythmia
27 locations incl. Scottsdale
Sponsor: AtaCor Medical, Inc.
Sex: All·Age: 18+
Code: NCT07324031·Recruiting·Listed Jan 2026
Advent Health
Clinical research site in Orlando, Florida · 9975 TAVISTOCK LAKES BLVD STE 140, ORLANDO, FL 32827-7665 · (407) 930-7803 · Website
Part of Advent Health
As of July 2026, 60 paid clinical trials are recruiting at Advent Health in Orlando, Florida. Active studies at this site cover conditions such as Acute Pancreatitis, Colonic Neoplasms and Heart Failure. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Advent Health (60)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
67 locations incl. Tucson
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
for Large B-cell Lymphoma
37 locations incl. Gilbert
Sponsor: Lyell Immunopharma, Inc.
Sex: All·Age: 18+
Code: NCT07188558·Phase 3·Recruiting·Listed Sep 2025
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
for Follicular Lymphoma (FL)
32 locations incl. Fresno
Sponsor: Genmab
Sex: All·Age: 18+
Code: NCT06191744·Phase 3·Recruiting·Listed Jan 2024
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
for Urinary Bladder Neoplasms
41 locations incl. Tucson
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT05614739·Phase 1·Recruiting·Listed Nov 2022
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
for Carcinoma, Non-small-Cell Lung
14 locations incl. La Jolla
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05498428·Phase 2·Recruiting·Listed Aug 2022
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for Chronic Inflammatory Demyelinating Polyneuropathy
31 locations incl. Homewood
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06290141·Phase 3·Recruiting·Listed Mar 2024
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for Heart Failure
85 locations incl. Alexander City
Sponsor: Cytokinetics
Sex: All·Age: 18 - 85
Code: NCT06736574·Phase 3·Recruiting·Listed Dec 2024
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
for Advanced Solid Tumor
31 locations incl. La Jolla
Sponsor: PMV Pharmaceuticals, Inc
Sex: All·Age: 12+
Code: NCT04585750·Phase 1, Phase 2·Recruiting·Listed Oct 2020
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
26 locations incl. Murrieta
Sponsor: Takeda
Sex: All·Age: 18 - 75
Code: NCT06233461·Phase 2·Recruiting·Listed Jan 2024
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for Relapsing Multiple Sclerosis
40 locations incl. Scottsdale
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 40 - 70
Code: NCT06846281·Phase 3·Recruiting·Listed Feb 2025
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for Prostate Cancer
25 locations incl. Palo Alto
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06855277·Phase 3·Recruiting·Listed Mar 2025
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for Prostate Cancer
27 locations incl. Los Angeles
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06780670·Phase 2, Phase 3·Recruiting·Listed Jan 2025
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for Breast Cancer
79 locations incl. Phoenix
Sponsor: BriaCell Therapeutics Corporation
Sex: All·Age: 18+
Code: NCT06072612·Phase 3·Recruiting·Listed Oct 2023
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
for Low Grade Serous Ovarian Cancer
38 locations incl. Phoenix
Sponsor: Verastem, Inc.
Sex: Female·Age: 18+
Code: NCT06072781·Phase 3·Recruiting·Listed Oct 2023
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
for Functional Mitral Regurgitation
51 locations incl. Gilbert
Sponsor: Cardiac Dimensions, Inc.
Sex: All·Age: 18+
Code: NCT03142152·Recruiting·Listed May 2017
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
for Cardiovascular Diseases
37 locations incl. Little Rock
Sponsor: BrioHealth Solutions, Inc.
Sex: All·Age: 18 - 100
Code: NCT06310031·Recruiting·Listed Mar 2024
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
for Brain Tumor, Recurrent
52 locations incl. Phoenix
Sponsor: GT Medical Technologies, Inc.
Sex: All·Age: All ages
Code: NCT04427384·Recruiting·Listed Jun 2020
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for Extensive Stage-small Cell Lung Cancer
25 locations incl. Birmingham
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06362252·Phase 1, Phase 2·Recruiting·Listed Apr 2024
Caris Biorepository Research Protocol
for Cancer
38 locations incl. Mobile
Sponsor: Caris Science, Inc.
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT01499394·Recruiting·Listed Dec 2011
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
for Type 2 Diabetes Mellitus
37 locations incl. Birmingham
Sponsor: Endogenex, Inc.
Sex: All·Age: 22 - 70
Code: NCT06267391·Recruiting·Listed Feb 2024
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
for Atrial Fibrillation
39 locations incl. Phoenix
Sponsor: Biosense Webster, Inc.
Sex: All·Age: 18 - 80
Code: NCT06455098·Recruiting·Listed Jun 2024
Impella RP Flex with Smart Assist
for Right Ventricular (RV) Dysfunction
31 locations incl. Birmingham
Sponsor: Abiomed Inc.
Sex: All·Age: All ages
Code: NCT06637644·Recruiting·Listed Oct 2024
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for Non-small Cell Lung Cancer (NSCLC)
12 locations incl. Los Angeles
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT07154706·Phase 3·Recruiting·Listed Sep 2025
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
for Colorectal Cancer
11 locations incl. Phoenix
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All·Age: 18+
Code: NCT06948448·Phase 2·Recruiting·Listed Apr 2025
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
for Pulmonary Hypertension
8 locations incl. Phoenix
Sponsor: Liquidia Technologies, Inc.
Sex: All·Age: 18 - 80
Code: NCT06129240·Recruiting·Listed Nov 2023
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
for Atrial Fibrillation (AF)
18 locations incl. Birmingham
Sponsor: Arga Medtech SA
Sex: All·Age: 18 - 80
Code: NCT06784466·Recruiting·Listed Jan 2025
Investigations of Reproductive Cancers in Women
for Uterine Cancer
13 locations incl. Birmingham
Sponsor: PinkDx, Inc.
Sex: Female·Age: 45 - 100
Code: NCT06527157·Recruiting·Listed Jul 2024
Vivistim Registry for Paired VNS Therapy (GRASP)
for Upper Extremity Problem
15 locations incl. Orlando
Sponsor: MicroTransponder Inc.
Sex: All·Age: 22+
Code: NCT05301140·Recruiting·Listed Mar 2022
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
for Generalized Myasthenia Gravis
24 locations incl. Phoenix
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 75
Code: NCT06744920·Phase 3·Recruiting·Listed Dec 2024
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
for Respiratory Distress Syndrome
12 locations incl. Little Rock
Sponsor: Aerogen Pharma Limited
Sex: All·Age: 1 Hour - 24 Hours
Code: NCT06776783·Phase 3·Recruiting·Listed Jan 2025
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
for Cachexia
12 locations incl. Beverly Hills
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05865535·Phase 1·Recruiting·Listed May 2023
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
for Alzheimer Disease
6 locations incl. Delray Beach
Sponsor: InSightec
Sex: All·Age: 50 - 85
Code: NCT03671889·Recruiting·Listed Sep 2018
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
for Non-muscle-invasive Bladder Cancer
19 locations incl. Mesa
Sponsor: SURGE Therapeutics
Sex: All·Age: 18+
Code: NCT05710848·Phase 1, Phase 2·Recruiting·Listed Feb 2023
Total Shoulder Arthroplasty Multi-Center Registry
for Shoulder Arthroplasty
15 locations incl. Phoenix
Sponsor: Arthrex, Inc.
Sex: All·Age: 18 - 100
Code: NCT03511586·Recruiting·Listed Apr 2018
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
for Pre-Bronchiolitis Obliterans Syndrome
18 locations incl. Los Angeles
Sponsor: Renovion, Inc.
Sex: All·Age: 18 - 75
Code: NCT05654922·Phase 3·Recruiting·Listed Dec 2022
SAfety of Regional Citrate Anticoagulation (SARCA Study)
for Acute Kidney Injury
6 locations incl. Little Rock
Sponsor: Fresenius Medical Care North America
Sex: All·Age: 18+
Code: NCT05339139·Phase 3·Recruiting·Listed Apr 2022
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
for Acute Kidney Injury
10 locations incl. Los Angeles
Sponsor: Talphera, Inc
Sex: All·Age: 18 - 80
Code: NCT06150742·Recruiting·Listed Nov 2023
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
for Epithelial Ovarian Cancer
8 locations incl. Orlando
Sponsor: Imunon
Sex: Female·Age: 18+
Code: NCT06915025·Phase 3·Recruiting·Listed Apr 2025
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
for Post Operative Pain
6 locations incl. Jacksonville
Sponsor: AtriCure, Inc.
Sex: All·Age: 12+
Code: NCT05110989·Recruiting·Listed Nov 2021
Showing the 40 most relevant of 60 recruiting trials at this site. Browse all with filters →
More research sites in Orlando
- AdventHealth Orlando (60 trials)
- Arnold Palmer Hospital for Children (37 trials)
- Nemours Children's Hospital (37 trials)
- Orlando Health (31 trials)
- University of Central Florida (31 trials)
- Orlando Health Cancer Institute (30 trials)
- AdventHealth (28 trials)
- Orlando Clinical Research Center (17 trials)
- Charter Research (11 trials)
- Advent Health Orlando (10 trials)
Explore more
Paid clinical trials in Orlando, FL · Florida clinical trials